European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - hepatitis b; hepatitis a; immunization - vaccines - ambirix is for use in non-immune persons from one year up to and including 15 years of age for protection against hepatitis-a and hepatitis-b infection.protection against hepatitis-b infections may not be obtained until after the second dose.therefore:ambirix should be used only when there is a relatively low risk of hepatitis-b infection during the vaccination course;it is recommended that ambirix should be administered in settings where completion of the two-dose vaccination course can be assured.

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - immunization; hepatitis b; hepatitis a - vaccines - twinrix paediatric is indicated for use in non-immune infants, children and adolescents from one year up to and including 15 years who are at risk of both hepatitis-a and hepatitis-b infection.

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - hepatitis b; hepatitis a; immunization - vaccines - twinrix adult is indicated for use in non immune adults and adolescents 16 years of age and above who are at risk of both hepatitis a and hepatitis b infection.

Canada - English - Health Canada

glaxosmithkline inc - hepatitis a virus, inactivated; hepatitis b surface antigen (recombinant) - suspension - 720unit; 20mcg - hepatitis a virus, inactivated 720unit; hepatitis b surface antigen (recombinant) 20mcg - vaccines

Canada - English - Health Canada

glaxosmithkline inc - hepatitis b surface antigen (recombinant); hepatitis a virus, inactivated - suspension - 10mcg; 360unit - hepatitis b surface antigen (recombinant) 10mcg; hepatitis a virus, inactivated 360unit - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - hepatitis a virus inactivated; hepatitis b virus surface antigen - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - hepatitis b virus surface antigen; hepatitis a virus inactivated - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - hepatitis a virus inactivated; hepatitis b virus surface antigen - suspension for injection

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - hepatitis a virus antigen (inactivated); hepatitis b surface antigen (r-dna) - injection - 720 elisa units/ml - hepatitis a virus antigen (inactivated) 720 elisa units/ml; hepatitis b surface antigen (r-dna) 20 mcg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - hepatitis a virus (hm175 strain) inactivated; salmonella typhi (ty2 strain) vi capsular polysaccharide - suspension for injection